Reaction

Papilloma reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 314 reports · 5 co-occurring drugs

As of the last recalculation, Papilloma appears in 314 FAERS reports alongside 5 co-occurring drug terms. The strongest observed disproportionality signal is VEMURAFENIB (PRR 111.5).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
DrugCo-reportsPRRROR
Vemurafenib19111.5111.6
Isoniazid1146.646.6
Amikacin936.036.0
Cabotegravir324.924.9
Encorafenib320.320.3

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.